Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

(2012) J. C. Jennette et al.   ARTHRITIS AND RHEUMATISM

Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): Ten-year experience at a single center

(2012) Rodrigo Cartin-Ceba et al.   ARTHRITIS AND RHEUMATISM

Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis

(2012) Rona M. Smith et al.   ARTHRITIS AND RHEUMATISM

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort

(2012) Cloé Comarmond et al.   ARTHRITIS AND RHEUMATISM

Classification of antineutrophil cytoplasmic autoantibody vasculitides: The role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis

(2012) Sophia Lionaki et al.   ARTHRITIS AND RHEUMATISM

Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome

(2012) Bridget Healy et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Proteinase 3, the Autoantigen in Granulomatosis with Polyangiitis, Associates with Calreticulin on Apoptotic Neutrophils, Impairs Macrophage Phagocytosis, and Promotes Inflammation

(2012) J. Gabillet et al.   JOURNAL OF IMMUNOLOGY

High Prevalence of Autoantibodies to hLAMP-2 in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

(2012) R. Kain et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Genetically Distinct Subsets within ANCA-Associated Vasculitis

(2012) Paul A. Lyons et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anti-Proteinase 3 Anti-Neutrophil Cytoplasm Autoantibodies Recapitulate Systemic Vasculitis in Mice with a Humanized Immune System

(2012) Mark A. Little et al.   PLoS One

The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis

(2012) R. A. Watts et al.   RHEUMATOLOGY

The contribution of genetic variation and infection to the pathogenesis of ANCA-associated systemic vasculitis

(2012) Lisa C Willcocks et al.   ARTHRITIS RESEARCH & THERAPY

Progress in treatment of ANCA-associated vasculitis

(2012) Rona M Smith et al.   ARTHRITIS RESEARCH & THERAPY

Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations

(2011) Julia U Holle et al.   ANNALS OF THE RHEUMATIC DISEASES

Pathogenesis of Antineutrophil Cytoplasmic Autoantibody–Associated Small-Vessel Vasculitis

(2011) J. Charles Jennette et al.   Annual Review of Pathology-Mechanisms of Disease

Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis

(2011) Michael Walsh et al.   ARTHRITIS AND RHEUMATISM

Cyclophosphamide as induction therapy for Wegener's granulomatosis and microscopic polyangiitis

(2011) C. A. Langford   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Pathogenesis of ANCA-associated vasculitis

(2011) Mirjan M. van Timmeren et al.   CURRENT OPINION IN RHEUMATOLOGY

Anti-LAMP-2 Antibodies Are Not Prevalent in Patients With Antineutrophil Cytoplasmic Autoantibody Glomerulonephritis

(2011) A. J. Roth et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

DRB1*15 Allele Is a Risk Factor for PR3-ANCA Disease in African Americans

(2011) Y. Cao et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The Five-Factor Score Revisited

(2011) Loïc Guillevin et al.   MEDICINE

Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis

(2011) G. Tomasson et al.   RHEUMATOLOGY

Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the UK

(2011) S. Fujimoto et al.   RHEUMATOLOGY

Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index

(2010) R. Suppiah et al.   ANNALS OF THE RHEUMATIC DISEASES

Alpha1-antitrypsin deficiency-related alleles Z and S and the risk of Wegener's granulomatosis

(2010) Alfred D. Mahr et al.   ARTHRITIS AND RHEUMATISM

Anti-PR3 immune responses induce segmental and necrotizing glomerulonephritis

(2010) V. C. Primo et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Wegener’s Granulomatosis Strictly and Persistently Localized to One Organ Is Rare: Assessment of 16 Patients from the French Vasculitis Study Group Database

(2010) CHRISTIAN PAGNOUX et al.   JOURNAL OF RHEUMATOLOGY

New pathophysiological insights and treatment of ANCA-associated vasculitis

(2010) Benjamin Wilde et al.   KIDNEY INTERNATIONAL

ANCA-associated vasculitides—advances in pathogenesis and treatment

(2010) Min Chen et al.   Nature Reviews Rheumatology

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010) Rachel B. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE

Epidemiology of ANCA-associated Vasculitis

(2010) Eleana Ntatsaki et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Successful Pregnancy and Delivery of a Healthy Newborn Despite Transplacental Transfer of Antimyeloperoxidase Antibodies From a Mother With Microscopic Polyangiitis

(2009) Francisco Silva et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Myeloperoxidase: Molecular Mechanisms of Action and Their Relevance to Human Health and Disease

(2009) Betty S. van der Veen et al.   ANTIOXIDANTS & REDOX SIGNALING

The environment, geoepidemiology and ANCA-associated vasculitides

(2009) Min Chen et al.   AUTOIMMUNITY REVIEWS

Interaction of proteinase 3 with its associated partners: implications in the pathogenesis of Wegenerʼs granulomatosis

(2009) Véronique Witko-Sarsat et al.   CURRENT OPINION IN RHEUMATOLOGY

Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides

(2008) B Terrier et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for the management of primary small and medium vessel vasculitis

(2008) C Mukhtyar et al.   ANNALS OF THE RHEUMATIC DISEASES

Mechanisms of ANCA-Mediated Leukocyte-Endothelial Cell Interactions In Vivo

(2008) S. L. Nolan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

C5a Receptor Mediates Neutrophil Activation and ANCA-Induced Glomerulonephritis

(2008) A. Schreiber et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis

(2008) Renate Kain et al.   NATURE MEDICINE

Hypotheses on the Etiology of Antineutrophil Cytoplasmic Autoantibody Associated Vasculitis: The Cause Is Hidden, but the Result Is Known

(2007) R. A.F. de Lind van Wijngaarden et al.   Clinical Journal of the American Society of Nephrology